Tags : Latin America

Takeda to Divest a Portfolio of Select OTC and Non-Core

Shots: Takeda will divest a portfolio of ~18 select OTC and prescription pharmaceutical assets including Neosaldina, Nesina, and Dramin sold in Brazil, Mexico, Argentina, Colombia, Ecuador, Panama and Peru to Hypera for a total value ~$825M. The transaction is expected to be close in H2’20 Takeda expects that its ~300 employees supporting the divested assets […]Read More